Navicular syndrome management changed significantly in 2014 when the U.S. Food and Drug Administration approved bisphosphonates for treatment. Sponsored by Dechra Veterinary Products.
Texas A&M researchers reviewed the current body of knowledge surrounding bisphosphonates and their use in horses. Here’s what they found.
Two leading researchers explain insulin’s effects on the body and how to manage the insulin-resistant horse.
Equine researchers recently found that calcium levels return to baseline within five days, suggesting that weekly furosemide administration in racehorses doesn’t lead to long-term calcium losses that might contribute to skeletal injuries.
Up to 93% of performance horses suffer from gastric ulcers. Is yours one of them? Here’s how to manage the condition.
It’s the most frequently diagnosed equine infectious disease in the world. Find out how researchers are working to develop better detection methods and vaccines for strangles.
Rapid Equine Solutions compounded the product, which was labeled as containing toltrazuril and pyrimethamine for the treatment of EPM.
Renowned veterinarians talk catastrophic injury prevention, uniform medication policies, and more in a Translational Medicine Institute video.
Australian researchers recently tested whether velagliflozin could help prevent laminitis in horses, and they say it’s showing promising results in early trials.
Scientists found 200 E. coli strains, about half of which were resistant to at least one microbial agent, in manure, air, and horse nostrils at Polish riding centers. Here’s what that means for you.
Proposals for research on how bisphosphonates impact racehorses and young racing prospects intended for sale at public auction must be submitted by Oct. 1.
This gift will help the University of Kentucky launch a world-class equine drug research and testing program under the direction of Scott Stanley, PhD.
Many factors affect your horse’s ability to mount an effective immune response, one of which is his age. Learn more about the horse’s immune system and how it functions at every stage of his life.
Beginning Jan. 1, 2020, 2-year-olds would be prohibited from receiving furosemide within 24 hours of a race at coalition tracks. Beginning in 2021, the same prohibition would extend to all horses participating in any stakes race.
Recommendations include avoiding using bisphosphonates in manners inconsistent with indications of use on the label and discontinuing bisphosphonates use in any horses in training regardless of age, having every jurisdiction employ a full-time equine medical director, and more.
Officials from the Keeneland Association, Fasig-Tipton Company, and Ocala Breeders’ Sales Company announced they will enable buyers of horses younger than 4 years old to have those horses tested for bisphosphonates.
Stay on top of the most recent Horse Health news with
